STAT

Opinion: An opioid shortage? It’s real and could harm cancer patients

Managing symptoms at the end of life are an important part of a person's journey with cancer. Opioids are an essential part of that management.

Most doctors and health policy experts these days are focused on the overabundance of pills fueling the opioid crisis gripping the United States. Cancer doctors like me lie awake at night worrying about the looming shortage of injectable opioids that we need to treat our in-pain and dying patients.

Patients like Tommy Hogan (all of the names in this article have been changed to protect patients’ identities). At age 40, he was diagnosed with lung cancer, even though he never smoked. Despite the best efforts of his medical team, the cancer continued to grow and spread to other parts of his body. Two years later, Tommy was in a home hospice program.

A few days

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
STAT1 min read
USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.
STAT1 min read
Opinion: STAT+: How AI Can Help Satisfy FDA’s Drug, Device Diversity Requirements
To meet the Food and Drug Omnibus Reform Act, companies must rethink their current clinical trial strategies. Including AI and machine learning approaches can help.

Related Books & Audiobooks